Andrographolide relieved pathological pain generated by spared nerve injury model in mice

Area of Science:

• Neuroscience
• Pharmacology
• Immunology

Background:

• Andrographolide (Andro), a compound from Andrographis paniculata, exhibits anti-inflammatory properties, particularly in the central nervous system (CNS).
• Chronic pain conditions like allodynia can significantly impact quality of life.

Purpose of the Study:

• To evaluate the efficacy of Andrographolide (Andro) in alleviating mechanical allodynia.
• To investigate Andro's effects in a spared nerve injury (SNI) mouse model.

Main Methods:

• Male BalbC mice underwent sham operation or spared nerve injury.
• Groups received daily intraperitoneal injections of saline, Andrographolide (5 mg/kg), or NSAIDs (diclofenac salt, 5 mg/kg).
• Mechanical allodynia was assessed using von Frey tests; spinal cord IL-1 levels were analyzed via immunohistochemistry.

Main Results:

• Andrographolide significantly reduced mechanical allodynia compared to both saline and NSAID treatments over 14 days.
• The anti-allodynic effect of Andro was more potent than NSAIDs at equivalent doses.
• Immunohistochemical analysis revealed reduced Interleukin-1 (IL-1) in the spinal cord of Andro-treated mice.

Conclusions:

• Andrographolide demonstrates superior efficacy in reducing mechanical allodynia compared to NSAIDs in a nerve injury model.
• The observed analgesic effect is associated with a decrease in pro-inflammatory cytokine production in the spinal cord.
• Andro represents a promising therapeutic agent for neuropathic pain management.